Monopar Therapeutics Inc(MNPR)
$72.00-0.68 (-0.94%)
MNPR
Monopar Therapeutics Inc earnings date
$72.00
At close:-0.68 (-0.94%)
Want to see MNPR full AI Analyst Report?
Monopar Therapeutics Inc (MNPR) Q2 2020 Earnings Report
583 Followers
MNPR Q2 2020 EPS Results
- Actual EPS
- -$0.14
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.09
MNPR Q2 2020 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 08/06/2020
- Time
- After Close
- Conference Call
- Thursday, August 6, 2020
MNPR Upcoming Earnings
Monopar Therapeutics Inc's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MNPR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | ―- | -0.64 | ― | ― |
| Nov 06, 2026 | 2026 (Q3) | -0.72-0.72 | -0.48 | -50.83% (-0.24) | |
| Aug 12, 2026 | 2026 (Q2) | -0.65-0.62 | -0.35 | -77.14% (-0.27) | |
| May 14, 2026 | 2026 (Q1) | -0.81-0.46 | -0.38 | -21.05% (-0.08) | |
| Mar 27, 2026 | 2025 (Q4) | -0.48-0.64 | -2.74 | 76.64% (+2.10) | |
| Nov 13, 2025 | 2025 (Q3) | -0.42-0.48 | -0.37 | -29.73% (-0.11) | |
| Aug 12, 2025 | 2025 (Q2) | -0.46-0.35 | -0.5 | 30.00% (+0.15) | |
| May 13, 2025 | 2025 (Q1) | ―-1.22 | -0.5 | -143.00% (-0.71) | |
| Mar 31, 2025 | 2024 (Q4) | -0.68-0.38 | -0.5 | 24.00% (+0.12) | |
| Nov 08, 2024 | 2024 (Q3) | -0.99-0.37 | -0.7 | 47.14% (+0.33) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

